COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
Viruses · 2023
DOI: 10.3390/v15040865 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Viruses, 2023. Verfasst von Helena C Maltezou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Directorate of Research, Studies and Documentation, National Public Health Organization, 15123 Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Coinfection, Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory virus co-infections as of 12 April 2022. SARS-CoV-2 and influenza co-infections were reported almost exclusively during the first pandemic wave. It is possible that the overall incidence of SARS-CoV-2 co-infections is higher because of the paucity of co-testing for respiratory viruses during the first pandemic waves when mild cases might have been missed. Animal models indicate severe lung pathology and high fatality; nevertheless, the available literature is largely inconclusive regarding the clinical course and prognosis of co-infected patients. Animal models also indicate the importance of considering the sequence timing of each respiratory virus infection; however, there is no such information in reported human cases. Given the differences between 2020 and 2023 in terms of epidemiology and availability of vaccines and specific treatment against COVID-19, it is rational not to extrapolate these early findings to present times. It is expected that the characteristics of SARS-CoV-2 and respiratory virus co-infections will evolve in the upcoming seasons. Multiplex real-time PCR-based assays have been developed in the past two years and should be used to increase diagnostic and infection control capacity, and also for surveillance purposes. Given that COVID-19 and influenza share the same high-risk groups, it is essential that the latter get vaccinated against both viruses. Further studies are needed to elucidate how SARS-CoV-2 and respiratory virus co-infections will be shaped in the upcoming years, in terms of impact and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Directorate of Research, Studies and Documentation, National Public Health Organization, 15123 Athens, Greece.
- Third Department of Internal Medicine, Sotiria General Hospital for Thoracic Diseases, National and Kapodistrian University of Athens, School of Medicine, Sotiria General Hospital, 11527 Athens, Greece.
- Nafplion General Hospital, 21100 Nafplion, Greece.
- Department of Microbiology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, 16121 Athens, Greece.
- Department of Hepatitides, National Public Health Organization, 15123 Athens, Greece.
- Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Helena C Maltezou, Nikolaos V Sipsas
Zitieren
APA
Maltezou, H. C., Papanikolopoulou, A., Vassiliu, S., Theodoridou, K., Nikolopoulou, G., & Sipsas, N. V. (2023). COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature. Viruses. https://doi.org/10.3390/v15040865
Vancouver
Maltezou HC, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas NV. COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature. Viruses. 2023. doi:10.3390/v15040865
BibTeX
@article{Maltezou2023,
author = {Maltezou, Helena C and Papanikolopoulou, Amalia and Vassiliu, Sofia and Theodoridou, Kalliopi and Nikolopoulou, Georgia and Sipsas, Nikolaos V},
title = {COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040865}
}
EUVIMED